🇺🇸 FDA
Pipeline program

BG-C0902

BG-C0902-101

Phase 1 small_molecule active

Quick answer

BG-C0902 for Solid Tumors is a Phase 1 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).

Program details

Company
BeOne Medicines
Indication
Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials